0001214659-20-010742.txt : 20201229
0001214659-20-010742.hdr.sgml : 20201229
20201229175344
ACCESSION NUMBER: 0001214659-20-010742
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201224
FILED AS OF DATE: 20201229
DATE AS OF CHANGE: 20201229
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Daniels Mark
CENTRAL INDEX KEY: 0001753840
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38720
FILM NUMBER: 201423526
MAIL ADDRESS:
STREET 1: C/O TWIST BIOSCIENCE CORPORATION
STREET 2: 455 MISSION BAY BOULEVARD SOUTH
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94158
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Twist Bioscience Corp
CENTRAL INDEX KEY: 0001581280
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 462058888
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0930
BUSINESS ADDRESS:
STREET 1: 681 GATEWAY BLVD.
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 800-719-0671
MAIL ADDRESS:
STREET 1: 681 GATEWAY BLVD.
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
4
1
marketforms-50726.xml
PRIMARY DOCUMENT
X0306
4
2020-12-24
0001581280
Twist Bioscience Corp
TWST
0001753840
Daniels Mark
C/O TWIST BIOSCIENCE CORPORATION
681 GATEWAY BLVD.
SOUTH SAN FRANCISCO
CA
94080
false
true
false
false
See Remarks
Common Stock
2020-12-24
4
M
false
620
23.33
A
69407
D
Common Stock
2020-12-24
4
S
false
620
167.79
D
68787
D
Common Stock
2020-12-28
4
M
false
377
8.82
A
69164
D
Common Stock
2020-12-28
4
S
false
377
167.10
D
68787
D
Employee Stock Option (right to buy)
23.33
2020-12-24
4
M
false
620
0
D
2029-10-23
Common Stock
620
21095
D
Employee Stock Option (right to buy)
8.82
2020-12-28
4
M
false
377
0
D
2027-09-28
Common Stock
377
3392
D
The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on September 15, 2020.
25% of the shares subject to the option vested on October 24, 2020, and 1/48th of the shares subject to the option vest on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.
The option is immediately exercisable. 10% of the shares subject to the option vested on September 28, 2017, 15% of the shares subject to the option vested on September 28, 2018, and 1/48th of the shares subject to the option vest on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.
Senior Vice President, Chief Legal Officer, Chief Ethics and Compliance Officer, and Secretary
/s/ William Solis, as Attorney-in-Fact for Mark Daniels
2020-12-29